<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>Dysregulation of Akt signaling is important in a broad range of diseases that includes <z:e sem="disease" ids="C1306459,C0006826" disease_type="Neoplastic Process" abbrv="">cancer</z:e>, <z:mp ids='MP_0002055'>diabetes</z:mp> and <z:e sem="disease" ids="C0018799" disease_type="Disease or Syndrome" abbrv="">heart disease</z:e> </plain></SENT>
<SENT sid="1" pm="."><plain>The role of Akt signaling in <z:e sem="disease" ids="C0006111" disease_type="Disease or Syndrome" abbrv="">brain disorders</z:e> is less clear </plain></SENT>
<SENT sid="2" pm="."><plain>We found that global <z:e sem="disease" ids="C0022116" disease_type="Disease or Syndrome" abbrv="">ischemia</z:e> in intact rats triggered expression and activation of the Akt inhibitor CTMP (carboxyl-terminal modulator protein) in vulnerable hippocampal neurons and that CTMP bound and extinguished Akt activity and was essential to <z:e sem="disease" ids="C0022116" disease_type="Disease or Syndrome" abbrv="">ischemia</z:e>-induced neuronal <z:hpo ids='HP_0011420'>death</z:hpo> </plain></SENT>
<SENT sid="3" pm="."><plain>Although <z:e sem="disease" ids="C0022116" disease_type="Disease or Syndrome" abbrv="">ischemia</z:e> induced a marked phosphorylation and nuclear translocation of Akt, phosphorylated Akt was not active in post-ischemic neurons, as assessed by kinase assays and phosphorylation of the downstream targets GSK-3beta and FOXO3A </plain></SENT>
<SENT sid="4" pm="."><plain><z:chebi fb="40" ids="33697">RNA</z:chebi> interference-mediated <z:mpath ids='MPATH_63'>depletion</z:mpath> of CTMP in a clinically relevant model of <z:hpo ids='HP_0001297'>stroke</z:hpo> restored Akt activity and rescued hippocampal neurons </plain></SENT>
<SENT sid="5" pm="."><plain>Our results indicate that CTMP is important in the <z:hpo ids='HP_0002180'>neurodegeneration</z:hpo> that is associated with <z:hpo ids='HP_0001297'>stroke</z:hpo> and identify CTMP as a therapeutic target for the amelioration of hippocampal injury and <z:hpo ids='HP_0100543'>cognitive deficits</z:hpo> </plain></SENT>
</text></document>